Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review

[1]  Y. Gong,et al.  Melatonin Pathway and Atenolol‐Related Glucose Dysregulation: Is There a Correlation? , 2016, Clinical and translational science.

[2]  D. Prabhakaran,et al.  Effectiveness of fixed dose combination medication ('polypills') compared with usual care in patients with cardiovascular disease or at high risk: A prospective, individual patient data meta-analysis of 3140 patients in six countries. , 2016, International journal of cardiology.

[3]  M. Woodward,et al.  Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis , 2016, The Lancet.

[4]  M. Shlipak,et al.  Effect of Intensive Versus Usual Blood Pressure Control on Kidney Function Among Individuals With Prior Lacunar Stroke: A Post Hoc Analysis of the Secondary Prevention of Small Subcortical Strokes (SPS3) Randomized Trial. , 2016, Circulation.

[5]  Anne Forster,et al.  Cluster Randomized Controlled Trial , 2015, Stroke.

[6]  D. Prabhakaran,et al.  TRIple pill vs Usual care Management for Patients with mild-to-moderate Hypertension (TRIUMPH): Study protocol. , 2014, American heart journal.

[7]  Martin McKee,et al.  Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. , 2013, JAMA.

[8]  Alan D. Lopez,et al.  A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[9]  D. Wald,et al.  Randomized Polypill Crossover Trial in People Aged 50 and Over , 2012, PloS one.

[10]  A. Hughes,et al.  Meta-Analysis of Dose-Response Relationships for Hydrochlorothiazide, Chlorthalidone, and Bendroflumethiazide on Blood Pressure, Serum Potassium, and Urate , 2012, Hypertension.

[11]  P. Sever,et al.  Hypertension management 2011: optimal combination therapy. , 2011, European heart journal.

[12]  James Brian Byrd,et al.  Combination therapy as initial treatment for newly diagnosed hypertension. , 2011, American heart journal.

[13]  M. Law,et al.  Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies , 2009, BMJ : British Medical Journal.

[14]  Michael G. Kenward,et al.  An improved approximation to the precision of fixed effects from restricted maximum likelihood , 2009, Comput. Stat. Data Anal..

[15]  Azra Mahmud,et al.  Low-Dose Quadruple Antihypertensive Combination: More Efficacious Than Individual Agents-A Preliminary Report , 2007, Hypertension.

[16]  F. Turnbull.  Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials , 2003, The Lancet.

[17]  N J Wald,et al.  Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials , 2003, BMJ : British Medical Journal.

[18]  B. Brenner,et al.  The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study. , 2003, Kidney international.

[19]  Tom Greene,et al.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. , 2002, JAMA.

[20]  Jan A Staessen,et al.  Cardiovascular protection and blood pressure reduction: a meta-analysis , 2001, The Lancet.

[21]  E. Lewis,et al.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.

[22]  G. Beck,et al.  Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. , 1997, Kidney international.

[23]  Mahboob Rahman,et al.  Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study , 2017, Hypertension.

[24]  C. Escobar Cervantes,et al.  [A randomized trial of intensive versus standard blood pressure control]. , 2016, Semergen.

[25]  Alison Brayfield.  Martindale : the complete drug reference , 2014 .

[26]  Kevin A Peterson,et al.  Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus , 2011 .

[27]  D. Wald,et al.  Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials , 2010 .

[28]  Michael G Kenward,et al.  The use of baseline covariates in crossover studies. , 2010, Biostatistics.

[29]  W. Elliott.  A Simplified Approach to the Treatment of Uncomplicated Hypertension: A Cluster-Randomized Controlled Trial , 2010 .